Visit our USA website
Search
192 results for
First Day at School
September 18, 2017
First Day at School: Easy Tips for Parents to Calm First Day Anxiety Starting school is the first major life event for many young children and a […]
New Alzheimer’s Studies Launch
August 5, 2020
New Alzheimer’s Studies Launch at Re:Cognition Health Re:Cognition Health is delighted to launch two new clinical trials, testing new-generation medications for Alzheimer’s disease. Our team […]
New Alzheimer’s Medications
January 27, 2025
Dr Emer MacSweeney, CEO and Medical Director at Re:Cognition Health shared her excitement with the Daily Express about the groundbreaking new Alzheimer’s drugs that are now available […]
Celebrating the Success of Clinical Trial
May 19, 2023
International Clinical Trials Day 20th May 2023 “Taking part in clinical research gives us hope – the breakthrough may be just around the corner – and we […]
The Spectrum of Alzheimer’s
February 22, 2021
The Spectrum of Alzheimer’s A recent study, undertaken by a Re:Cognition Health USA Principal Investigator Dr R. Scott Turner, confirms that both Mild Cognitive Impairment (MCI) […]
The Importance of Strong Immunity
March 25, 2020
The Importance of Strong Immunity Having a strong, healthy immune system is imperative in helping to fight off potentially harmful viruses and bacteria, such as the coronavirus. […]
Recognition Health at the Alzheimer’s Show
June 11, 2019
Thank you to everyone who came to see Re:Cognition Health at the Alzheimer’s Show on the weekend- what an insightful show it was! Our team thoroughly enjoyed […]
New Autism Clinic Launched at Re:Cognition Health
September 9, 2021
New Autism Clinic Launched at Re:Cognition Health Re:Cognition Health is delighted to launch the new Autism Clinic, expanding our highly successful Children & Young People Service […]
A New Milestone in Alzheimer’s Treatment: MHRA Approves Lecanemab (Leqembi™)
August 22, 2024
PRESS RELEASE. Re:Cognition Health is delighted to offer this new treatment Re:Cognition Health is delighted with the announcement that the MHRA has approved Lecanemab, a pioneering treatment […]
Emer Fox5 News
August 11, 2022
Dr Emer MacSweeney, CEO, Medical Director and Consultant Neuroradiologist at Re:Cognition Health appeared on Fox5 News, USA, talking about the exciting and important opportunity provided through clinical […]